Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/130147
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Intragastric administration of leucine and isoleucine does not reduce the glycaemic response to, or slow gastric emptying of, a carbohydrate-containing drink in type 2 diabetes |
Author: | Elovaris, R.A. Hajishafiee, M. Ullrich, S.S. Ce Fitzgerald, P. Lange, K. Horowitz, M. Feinle-Bisset, C. |
Citation: | Diabetes Research and Clinical Practice, 2021; 171:1-8 |
Publisher: | Elsevier |
Issue Date: | 2021 |
ISSN: | 0168-8227 1872-8227 |
Statement of Responsibility: | Rachel A. Elovaris, Maryam Hajishafiee, Sina S. Ullrich, Penelope C.E. Fitzgerald,Kylie Lange, Michael Horowitz, Christine Feinle-Bisset |
Abstract: | AIMS: In healthy individuals, intragastric administration of the branched-chain amino acids, leucine and isoleucine, diminishes the glycaemic response to a mixed-nutrient drink, apparently by stimulating insulin and slowing gastric emptying, respectively. This study aimed to evaluate the effects of leucine and isoleucine on postprandial glycaemia and gastric emptying in type-2 diabetes mellitus (T2D). METHODS: 14 males with T2D received, on 3 separate occasions, in double-blind, randomised fashion, either 10g leucine, 10g isoleucine or control, intragastrically 30 min before a mixed-nutrient drink (500 kcal; 74g carbohydrates, 18g protein, 15g fat). Plasma glucose, insulin and glucagon were measured from 30 min pre- until 120 min post-drink. Gastric emptying of the drink was also measured. RESULTS: Leucine and isoleucine stimulated insulin, both before and after the drink (all P<0.05; peak (mU/L): control: 70±15; leucine: 88±17; isoleucine: 74±15). Isoleucine stimulated (P<0.05), and leucine tended to stimulate (P=0.078), glucagon before the drink, and isoleucine stimulated glucagon post-drink (P=0.031; peak (pg/mL): control: 62±5; leucine: 70±9; isoleucine: 69±6). Neither amino acid affected gastric emptying or plasma glucose (peak (mmol/L): control: 12.0±0.5; leucine: 12.5±0.7; isoleucine: 12.0±0.6). CONCLUSIONS: In contrast to health, in T2D, leucine and isoleucine, administered intragastrically in a dose of 10 g, do not lower the glycaemic response to a mixed-nutrient drink. This finding argues against a role for 'preloads' of either leucine or isoleucine in the management of T2D. |
Keywords: | Branched-chain amino acids blood glucose glucagon glucoregulatory hormones human insulin |
Rights: | © 2020 Elsevier B.V. All rights reserved. |
DOI: | 10.1016/j.diabres.2020.108618 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1103020 http://purl.org/au-research/grants/nhmrc/1158296 |
Published version: | http://dx.doi.org/10.1016/j.diabres.2020.108618 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.